Solid Tumors Research Scholars Program supports junior faculty investigators pursuing innovative solid tumor research to close knowledge gaps, address unmet patient needs, and tackle health inequities.
Applications are now closed; the page removed the November 13, 2026, 11:59 PM PST deadline and replaced “Apply Now” with “Subscribe.” You can subscribe to be notified when the program opens.
Funder: Gilead Sciences Research Scholars Program
Due Dates (Anticipated): Not yet announced
Funding Amounts: Up to $180,000 USD over 2 years, including indirect costs
Summary: Supports emerging investigators pursuing innovative solid tumor research addressing knowledge gaps, unmet patient needs, and health inequities.
Key Information: Applicants must meet NIH Early Stage Investigator criteria; Gilead-product research and drug-intervention trials are excluded.
The Solid Tumors Research Scholars Program, run by the Gilead Sciences Research Scholars Program, supports innovative research by junior faculty investigators. It seeks new perspectives that advance scientific understanding of solid tumors, address gaps in knowledge, and drive medical breakthroughs in areas of unmet medical need.
The program emphasizes diverse voices and research topics, including work addressing unmet patient needs and health inequities. It also aims to support research in settings that might not typically receive funding, with the potential to inform innovative interventions and clinical care. A Scientific Review Committee composed of leaders in solid tumors selects proposals based on scientific merit, feasibility, and innovation.